Campus News
June 7, 2010
H1N1 response gets national praise
The Emory University Institutional Review Board has received special recognition from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health for its work in support of Emory’s H1N1 emergency response and research.
As one of eight national Vaccine and Treatment Evaluation Units sponsored by the NIH, Emory was part of last summer’s critical national review of H1N1 vaccines through clinical trials.
The Emory IRB was able to rapidly and thoroughly review vaccine protocols, and the Emory Vaccine Center began enrolling adults, children and asthma patients in August in clinical trials of H1N1 vaccines. The clinical trials evaluated vaccine safety and immunogenicity, in addition to determining how best to give the H1N1 vaccine safely.
“Your dedication, perseverance, and commitment to excellence were essential for carrying out the rapid response to the H1N1 pandemic,” reads the certificate of recognition.
